References with Peptide ELISA

Peptide ELISA for Research

Peptide ELISA is an essential tool for measuring antigen-specific immune responses and assessing the efficacy of vaccines and immunotherapies. JPT’s Peptide ELISA technology supports various applications, including cancer research and infectious disease studies. Below, you will find key studies referencing JPT’s Peptide ELISA in research.

References with Peptide ELISA

2023

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapyHoefges et al., BioRXiv (2023) - PMID: 36896021

Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platformPanasiuk et al., Frontiers in Microbiology (2023) - PMID: 36922971

2021

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLoyal et al., Science (2021) - PMID: 34465633

R1441G but not G2019S Mutation Enhances LRRK2 Mediated Rab10 Phosphorylation in Human Peripheral Blood NeutrophilsFan et al., Acta Pathol. (2021) - PMID: n.a.

JNJ-64794964 (AL-034/TQ-A3334), a TLR7 Agonist, Induces Sustained Anti-HBV Activity in AAV/HBV Mice Via Non-Cytolytic MechanismsHerschke et al., Antiviral Research (2021)

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor ModelAkache et al., Pharmaceutical Research (2021) - PMID: 33673382

COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective ImmunityJeong et al., Vaccine (2021) - PMID: 34579194

A Rapid and Reliable Liquid Chromatography/mass Spectrometry Method for SARS-CoV-2 Analysis from Gargle Solutions and SalivaKipping et al., Analytical and Bioanalytical Chemistry (2021) - PMID: 34427712

SARS-CoV-2 Protein Subunit Vaccination of Mice and Rhesus Macaques Elicits Potent and Durable Neutralizing Antibody ResponsesMandolesi et al., Cell Reports Medicine (2021) - PMID: 33842900

Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineeringOng et al., Computational and Structural Biotechnology Journal (2021) - PMID: 33398234

Single Prime hAd5 Spike (S) + Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean S- and N- T-Cell Responses Equivalent to T-Cell Responses from Patients Previously Infected with SARS-CoV-2Sieling et al., MedRXiv (2021)

A Highly Specific Assay for the Detection of SARS-CoV-2–Reactive CD4+ and CD8+ T Cells in COVID-19 PatientsZelba et al., Journal of Immunology (2021) - PMID: 33298615

Archive

Serological Profiling of the EBV Immune Response in Chronic Fatigue Syndrome using a Peptide MicroarrayLoebel et al., PLoS One (2017) - PMID: 28604802

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Huber et al., PLoS One (2017) - PMID: 28056100

Evaluating the Efficacy of Aluminium Phosphate Formulated L2 Based HPV VaccineLakshmikanth et al., Asian Journal of Pharmaceutical and Clinical Research (2015) - PMID: n.a

Restrictive IgG Antibody Response Against Mutated Citrullinated Vimentin Predicts Response to Rituximab in Patients with Rheumatoid ArthritisLindenberg et al., Arthritis Research & Therapy (2015) - PMID: 26268352

052. Patients with Early Inflammatory Arthritis Who are Anti-CCP Antibody Positive have Antibodies Against Acetylated and Carbamylated Vimentin PeptidesJuarez et al., Rheumatology (2015) - PMID: n.a.

Identification of Novel Antiacetylated Vimentin Antibodies in Patients with Early Inflammatory ArthritisJuarez et al., Ann Rheum Dis (2015) - PMID: n.a